Dr Sin Yong · MBBS (NUS) · MRCS (Edin) · MSc Aesthetic Medicine (London) · MSc Practical Dermatology (Cardiff) · International KOL
Sculptra is injectable poly-L-lactic acid. It adds no lasting volume of its own; it is a scaffold the skin builds collagen around over months, and it cannot be dissolved — assessed and placed by Dr Sin Yong at Orchard Road, Singapore.
Sculptra is poly-L-lactic acid, a synthetic polymer that has been used in dissolvable sutures and orthopaedic implants for decades. For aesthetic use it is supplied as a dry powder of microparticles which is mixed with sterile water, usually a day or more before treatment, and then injected into the deeper layers of the skin or just beneath them.
It is not a filler in the ordinary sense. A hyaluronic acid filler is a gel that occupies space the moment it is placed. Poly-L-lactic acid occupies very little space of its own. What it does is provoke a response: fibroblasts treat the particles as a scaffold and lay down new collagen around them over the following weeks and months, while the particles themselves slowly break down by hydrolysis. What remains is your own collagen, not resident product.
That distinction decides everything else about how it behaves — the timing of the result, the areas it suits, and what can be done if it goes wrong.
The fullness visible immediately after a Sculptra treatment is almost entirely the water it was mixed with, plus the swelling that follows any injection. Both settle within days, and the face often looks much as it did before. This is normal and is the point at which people who were not warned decide the treatment has failed.
The real change is slower. Collagen is produced over weeks, and the visible effect builds gradually across the months that follow. That tempo is the reason the product cannot be judged on the day, and the reason it is the wrong choice for anyone who needs a change before a near event.
It is also the reason conservative dosing matters more here than with any hyaluronic acid product. Because the response continues after the appointment, placing enough on the day to see a result is the commonest route to too much later — and too much cannot be taken back.
Hyaluronidase, the enzyme used to reverse hyaluronic acid filler, has no action on poly-L-lactic acid. If Sculptra is placed too superficially, in the wrong plane, or in excess, the options are time, targeted treatment of any nodules, and in some cases procedural removal. None of those is equivalent to dissolving.
The US pivotal trial reported papules or nodules in 17.2% of patients, typically appearing months after treatment and mostly resolving on their own. Dilution, depth of placement and post-treatment massage all influence that figure, which is why technique rather than brand is the variable that matters. Any lump that is growing, painful or red deserves examination rather than reassurance.
Correction of biostimulator problems from treatment elsewhere is its own discipline and is assessed under filler correction, usually with ultrasound first to establish what material is present and where.
“Sculptra does not add volume. It asks the skin to build it, and the skin sets the pace. Anyone who shows you the result on the day is showing you water.”
Dr Sin YongOn what poly-L-lactic acid actually does
Sculptra is a planning product more than an injecting product. The decisions that determine the result are made before the needle: how much water the powder is reconstituted with, which plane each region is placed in, and how much is placed at a first visit against how much is left for reassessment.
Dr Sin Yong plans dilution and plane region by region rather than at one setting for the whole face — the temple, the mid-face and the pre-jowl area are different depths and different tissues, and a single dilution does not serve all three. He under-corrects deliberately, reviews as the collagen response develops, and decides any further placement from what the skin has actually produced rather than from a pre-sold plan.
Where the face has had other injectables before, he maps what is already present first. Layering a non-dissolvable product over unknown previous material is the situation that makes later correction hardest, and it is avoided rather than managed.
It suits diffuse, structural volume loss: the overall deflation of the mid-face, temples and lower face that comes with age or after significant weight loss, in a patient who can wait for a gradual result and who understands it cannot be reversed. It is particularly logical where the complaint is a face that reads tired rather than lined.
It does not suit the lips, the tear troughs or fine superficial lines — areas that punish a non-dissolvable product placed close to the surface. For those, a reversible hyaluronic acid product or a different approach is the honest recommendation. It does not lift: a jowl or a loose jawline is a laxity problem and belongs to focused ultrasound or the VF Lift – Vertical Facelift, not to an injectable.
It is also not interchangeable with its neighbours. Ellansé and Radiesse both give some volume on the day and stimulate collagen afterwards; Sculptra gives almost none on the day. Which is appropriate is an anatomical decision made at assessment, not a preference.
A face that has been injected more than once often arrives with a complaint that sounds like it needs more product — a heaviness in the lower face, a fullness under the eyes, a lump that has appeared months after the last visit. In Dr Sin Yong's experience the opposite is more often true: the problem is what is already there, and the answer is subtraction, not addition.
So before any further Sculptra is placed, he scans. High-frequency ultrasound shows what material is sitting in the tissue, how deep it is, whether it has migrated, and whether a lump is poly-L-lactic acid, old hyaluronic acid filler, a cyst, or scar. Each of those is managed differently, and two of them are made worse by injecting on top. A scan takes minutes and changes the plan more often than not.
If the scan shows that less is what you need, that is a different procedure with its own planning — see filler correction. If it shows a clean field, Sculptra can be placed with confidence rather than hope. Either way, nothing is added to a face that has not been looked beneath.
The common findings are those of any deep injectable: swelling, bruising, tenderness and temporary asymmetry while the water settles. Papules and nodules are the specific risk of this product and are discussed above. The serious risks are the vascular ones that attend any product placed near facial vessels, which is why plane and anatomy matter more than the product.
Poly-L-lactic acid is broken down by the body over time, so the change is not lifelong; the skin returns to its own trajectory as the collagen it produced ages like the rest. No specific duration quoted to you is a prediction for your face.
Vleggaar D, Fitzgerald R, Lorenc ZP. Composition and mechanism of action of poly-L-lactic acid in soft tissue augmentation. Journal of Drugs in Dermatology 2014;13(4 Suppl):s29–s31. source
US Food and Drug Administration. SCULPTRA® Aesthetic (injectable poly-L-lactic acid): summary of safety and effectiveness and labelling, P030050/S002, 2009. source
Vleggaar D. Facial volumetric correction with injectable poly-L-lactic acid. Dermatologic Surgery 2005;31(11 Pt 2):1511–1517. source
Wortsman X. Identification and complications of cosmetic fillers: sonography first. Journal of Ultrasound in Medicine 2015;34(7):1163–1172. source
Singapore Medical Council. Guidelines on Aesthetic Practices for Doctors, 2016 Edition. source
Medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last updated 2 October 2026
Whether a non-dissolvable biostimulator is the right answer depends on the anatomy, on what has been injected before, and on how much time you have. Dr Sin Yong assesses that first.
Arrange a consultation